Curanex Pharmaceuticals Inc Common Stock (CURX) vs Quince Therapeutics, Inc. (QNCX)

A side-by-side comparison of Curanex Pharmaceuticals Inc Common Stock and Quince Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Curanex Pharmaceuticals Inc Common Stock logo
CURX
Curanex Pharmaceuticals Inc Common Stock
$7M
$4.99HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Quince Therapeutics, Inc. logo
QNCX
Quince Therapeutics, Inc.
$7M
$26.81HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — CURX vs QNCX

growth of $100 · dividends reinvested · last 1y
CURX -93.8% (-93.8%/yr)QNCX -91.1% (-91.1%/yr)QNCX compounded faster over this window
0100200300Start $1002026$6$9
CURX QNCX

CURX vs QNCX: by the numbers

  • •QNCX is the larger company ($7M vs $7M market cap).

Metrics side by side

Valuation

MetricCURXQNCX
P/B ratio1.48N/A

Profitability

MetricCURXQNCX
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-218.65%-85.24%
ROIC-208.39%-107.08%

Growth (annualized)

MetricCURXQNCX
Total return CAGR (5Y)N/A-72.96%

Go deeper

Full CURX analysisFull QNCX analysisInteractive comparison tool

Dig into the metrics

Curanex Pharmaceuticals Inc Common Stock ROEQuince Therapeutics ROECuranex Pharmaceuticals Inc Common Stock operating marginQuince Therapeutics operating marginCuranex Pharmaceuticals Inc Common Stock revenue growthQuince Therapeutics revenue growthCuranex Pharmaceuticals Inc Common Stock free cash flowQuince Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.